CASE REPORT
Lethal acute liver failure in a 60 y/o female patient with AILD III (Ann Arbor) T-cell lymphoma in remission state – Case report
 
More details
Hide details
1
Scientific Society of Students at the Department of Internal Medicine, Medical University, Lublin, Poland
2
Department of Internal Medicine, Medical University, Lublin, Poland
CORRESPONDING AUTHOR
Anna Grzywa-Celińska   

Staszica 16, 20-081 Lublin, Poland
 
J Pre Clin Clin Res. 2014;8(1):41–43
KEYWORDS
ABSTRACT
Acute liver failure (ALF) is a rare condition in which liver function deteriorates suddenly, leading to encelopathy and coagulopathy in patients previously unaffected with hepatic cirrhosis. The case is presented of a 60-year-old woman admitted to our Department with complaints of general malaise, excessive sweating and body temperature elevation. Her history was relevant in terms of T-cell lymphoma in remission, hypertension and paroxysmal atrial fibrillation. The patient only reported using methylprednisolone in 4–8 mg daily dosage. Liver function tests were abnormal, with considerably elevated ALT, AST and GGTP concentrations. Diagnostic imaging revealed non-dilated biliary ducts, hepatomegaly and a single enlarged lymph node between the inferior vena cava and hepatic portal vein. A needle biopsy of the liver was non-diagnostic due to protein masses blurring the specimen. Autoimmune markers and investigation for Wilson’s disease both presented no alterations. The patient presented hyperthyroidism with no signs of thyrotoxicosis, significant leukocytosis with granulocytosis and thrombocytopenia. Her state deteriorated rapidly despite aggressive pharmacological treatment. The patient died before a needle core biopsy could be performed; no post-mortem examination was carried out at the request of the family. ALF should be suspected in every patient who exhibits highly elevated hepatic enzymes and whose condition is deteriorating rapidly. In our investigation, we should primarily focus on histopathological examination and qualifying the patient for the liver transplantation.
 
REFERENCES (15)
1.
Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure, Lancet 2010; 17; 376 (9736): 190–201.
 
2.
Mach T, Szulewski P. Acute Liver Failure, Gastroenterol. Pol. 2008; 15(3): 181–185.
 
3.
William M. Lee. Acute Liver Failure, N Engl J Med 1993; 329: 1862–1872.
 
4.
Armstrong LA, Toro DH, Martinez-Souss J, Chinea B, Conde-Sterling D. Anaplastic T-cell lymphoma presenting as fatal acute liver failure, P R Health Sci J. 2005; 24(4): 343–346.
 
5.
Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases, Gut 1998; 42(4): 576–580.
 
6.
Davis ML, Hashemi N. Acute liver failure as a rare initial manifestation of peripheral T-cell lymphoma, World J Hepatol 2010; 2(10): 384–386.
 
7.
Ortin X, Rodríguez-Luaces M, Bosch R, Lejeune M, Font L. Acute liver failure as the first manifestation of very late relapsing of Hodgkin’s disease, Hematol Rep 2010; 2(1): e5.
 
8.
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Acute Liver Failure Study Group, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med 2002; 137: 947–954.
 
9.
Dellon ES, Morris SR, Tang W, Dunphy CH, Russo MW. Acute liver failure due to natural killer-like T cell leukemia/lymphoma: A case report and review of the literature, World J Gastroenterol 2006; 12(25): 4089–4092.
 
10.
Nakagawa M, Terashima T, D’yachkova Y, Bondy GP, Hogg JC, van Eeden SF. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes, Circulation 1998; 98(21): 2307–2313.
 
11.
Shoenfeld Y, Gurewich Y, Gallant LA, Pinkhas J. Prednisoneinduced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis, Am J Med 1981; 71(5): 773–778.
 
12.
Crockard AD, Boylan MT, Droogan AG, McMillan SA, Hawkins SA. Methylprednisolone- induced neutrophil leukocytosis—downmodulation of neutrophil L-selectin and Mac-1 expression and induction of granulocyte-colony stimulating factor, Int J Clin Lab Res 1998; 28(2): 110–115.
 
13.
Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH Jr, Fontana RJ, Lee WM, Schilsky ML. Pediatric and Adult Acute Liver Failure Study Groups, Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests, Hepatology 2008; 48(4): 1167–1174.
 
14.
Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure, Gastroenterology, 1991; 100(4): 1129–1134.
 
15.
Sallie R, Katsiyiannakis L, Baldwin D, Davies S, O‘Grady J, Mowat A, Mieli-Vergani G, Williams R. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson‘s disease from other causes of fulminant liver failure, Hepatology 1992; 16(5): 1206- 1211.
 
eISSN:1898-7516
ISSN:1898-2395